CN1272794A - 碳化树脂dna免疫吸附剂的制备方法 - Google Patents
碳化树脂dna免疫吸附剂的制备方法 Download PDFInfo
- Publication number
- CN1272794A CN1272794A CN99800883A CN99800883A CN1272794A CN 1272794 A CN1272794 A CN 1272794A CN 99800883 A CN99800883 A CN 99800883A CN 99800883 A CN99800883 A CN 99800883A CN 1272794 A CN1272794 A CN 1272794A
- Authority
- CN
- China
- Prior art keywords
- dna
- resin
- stupid
- temperature
- carbide resin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000011347 resin Substances 0.000 title claims abstract description 72
- 229920005989 resin Polymers 0.000 title claims abstract description 72
- 238000000034 method Methods 0.000 title claims abstract description 14
- 239000003463 adsorbent Substances 0.000 claims abstract description 34
- 239000004372 Polyvinyl alcohol Substances 0.000 claims abstract description 7
- 229920002451 polyvinyl alcohol Polymers 0.000 claims abstract description 7
- 235000019422 polyvinyl alcohol Nutrition 0.000 claims abstract description 7
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims abstract description 5
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000019400 benzoyl peroxide Nutrition 0.000 claims abstract description 5
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims abstract 6
- 239000004342 Benzoyl peroxide Substances 0.000 claims abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 239000003547 immunosorbent Substances 0.000 claims description 15
- 238000010521 absorption reaction Methods 0.000 claims description 10
- 239000004088 foaming agent Substances 0.000 claims description 9
- 238000002649 immunization Methods 0.000 claims description 8
- 230000003053 immunization Effects 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000000178 monomer Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 238000003756 stirring Methods 0.000 claims description 8
- 239000003999 initiator Substances 0.000 claims description 7
- 239000003431 cross linking reagent Substances 0.000 claims description 6
- 229940068984 polyvinyl alcohol Drugs 0.000 claims description 6
- 230000004913 activation Effects 0.000 claims description 5
- 244000309466 calf Species 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 5
- 238000006116 polymerization reaction Methods 0.000 claims description 5
- 210000001541 thymus gland Anatomy 0.000 claims description 5
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 239000003208 petroleum Substances 0.000 claims description 4
- 239000000020 Nitrocellulose Substances 0.000 claims description 3
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 claims description 3
- 125000002252 acyl group Chemical group 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229920001220 nitrocellulos Polymers 0.000 claims description 3
- 239000012074 organic phase Substances 0.000 claims description 3
- 229920000642 polymer Polymers 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 2
- 229910052756 noble gas Inorganic materials 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical group C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 claims 2
- 239000008346 aqueous phase Substances 0.000 claims 2
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 claims 1
- 239000001993 wax Substances 0.000 claims 1
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 abstract description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 abstract description 6
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 239000002994 raw material Substances 0.000 abstract description 2
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 19
- 210000004369 blood Anatomy 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 238000000576 coating method Methods 0.000 description 8
- 230000036039 immunity Effects 0.000 description 8
- 239000011248 coating agent Substances 0.000 description 7
- 230000010412 perfusion Effects 0.000 description 7
- 238000002560 therapeutic procedure Methods 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 230000008081 blood perfusion Effects 0.000 description 6
- 238000011084 recovery Methods 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- 238000010792 warming Methods 0.000 description 5
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 239000012876 carrier material Substances 0.000 description 4
- 230000002969 morbid Effects 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- 230000004083 survival effect Effects 0.000 description 4
- 239000008215 water for injection Substances 0.000 description 4
- 238000003763 carbonization Methods 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- PKDBCJSWQUOKDO-UHFFFAOYSA-M 2,3,5-triphenyltetrazolium chloride Chemical compound [Cl-].C1=CC=CC=C1C(N=[N+]1C=2C=CC=CC=2)=NN1C1=CC=CC=C1 PKDBCJSWQUOKDO-UHFFFAOYSA-M 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 238000013019 agitation Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000004062 sedimentation Methods 0.000 description 2
- 235000002639 sodium chloride Nutrition 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000252234 Hypophthalmichthys nobilis Species 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 241000219991 Lythraceae Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 235000014360 Punica granatum Nutrition 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000011149 active material Substances 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 230000003172 anti-dna Effects 0.000 description 1
- 230000003460 anti-nuclear Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 150000003851 azoles Chemical class 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- 238000005255 carburizing Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000005660 chlorination reaction Methods 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000001105 femoral artery Anatomy 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000008236 heating water Substances 0.000 description 1
- 230000001951 hemoperfusion Effects 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000005201 scrubbing Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 239000012498 ultrapure water Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G02—OPTICS
- G02B—OPTICAL ELEMENTS, SYSTEMS OR APPARATUS
- G02B27/00—Optical systems or apparatus not provided for by any of the groups G02B1/00 - G02B26/00, G02B30/00
- G02B27/01—Head-up displays
- G02B27/017—Head mounted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06F—ELECTRIC DIGITAL DATA PROCESSING
- G06F1/00—Details not covered by groups G06F3/00 - G06F13/00 and G06F21/00
- G06F1/16—Constructional details or arrangements
- G06F1/1613—Constructional details or arrangements for portable computers
- G06F1/163—Wearable computers, e.g. on a belt
Landscapes
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Theoretical Computer Science (AREA)
- Computer Hardware Design (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Human Computer Interaction (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Studio Devices (AREA)
- Closed-Circuit Television Systems (AREA)
- External Artificial Organs (AREA)
- Medicines Containing Plant Substances (AREA)
- Non-Alcoholic Beverages (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (2)
- 权利要求'1、 一种 DNA免疫吸附剂的制备方法, 它使 碳化树脂作为载体, 在其上固 定了有效量的 DNA, DNA的含量 Q.3-0.5mg/ml树脂, 其特征在于, 该方 法包括下列步骤:( 3 ) 制备碳化树脂以笨乙烯和丙烯腈为单体, 以二乙烯笨为交联剂, 以三倍于单体和交联 剂 (重量比) 的曱笨和液体 ^蜡为致孔剂, 以过氧化苯曱酰为引发剂, 以 1- 2%聚乙烯醇水溶液为分教介质, 进行悬浮聚合, 在 S0 °C 温度下反应 5小时; 然后, 在 96 t温度下蒸馏甲笨, 再在 100 eC温度下将球体聚合物煮沸 2-3小 时, 使其进一步聚合和硬化; 然后, 用热水洗涤, 在 50 eC 温度下烘干, 再 用石油醚淋洗脱碏 , 获得三元共聚超大孔树脂;将上述树脂放入电阻炉中, 在惰气保护下, 在 100-300 eC 的温度下予烧 8-10小时, 然后升温至 500-800 eC, 再通入水蒸气活化 0.5-1.0小时后冷却, 即获得碳化树脂;( ) 制备碳化树脂 DNA免疫'疆剂把小牛胸腺 DNA溶液与火撺^ L乙瞇溶液混合均匀后, 一边迅速搅拌, 一边 加入经迚予处理的碳化树脂, 使液体很快被吸千, 然后用 50-60 的热水浴 恒温淋洗 2小^, 并不时搅拌, 至溶射完全揮发, 再在 50° (:温度下真空干燥 2 '〗、时, 用水漂洗数 ^洗条塔林' 直到流 液在 260nm处无紫外吸 收, 然后再漂洗数遍, 在 50t真空下干燥, ^"获得成品吸附剂。
- 2、 如权利要求 1所迷的 DNA免疫吸 ^剂的制备方法, 其特征在于, 各种物 料的配比为:( 1 ) 制备碳化树脂过程中: 有; 目由单体笨乙烯 5.0-7.5%w/w, 丙烯腈 7.5-10.0%w/w,交联剂二乙烯苯 10.0-12.5%w/w,致孔剂 甲笨 50.0%w/w,液体石蜡 25.0%w/w 和引发剂过氧化笨甲酰 0.15- 0.3%w/w组成, 引发剂过氧化苯曱酰为笨乙烯和二乙烯苯总量的 0.5-1.0%, 水相为 1-2%聚乙烯醇溶液,有机相与水相的重量比为 1 : 2;( 2 ) 制备免疫吸附剂过程中: 碳化树脂 57.1-59.5%v/v,DNA 溶液 19- 20%v/v,火棉胶乙醚溶液 21.4-22.9%v/v, DNA浓度为 1.33mg ml, 火 棉胶浓度为 0.68%,——替换页(细则第 26条)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN98102335A CN1203805A (zh) | 1998-06-04 | 1998-06-04 | 防治月经病证保健饮料 |
CN98102355.X | 1998-06-08 | ||
CN98102335.X | 1998-06-08 | ||
AU90525/98A AU708728B1 (en) | 1998-06-04 | 1998-11-04 | Video camera system |
CA002252786A CA2252786C (en) | 1998-06-04 | 1998-11-04 | Video camera system |
EP98309219A EP1001618A1 (en) | 1998-06-04 | 1998-11-11 | Video camera system |
JP10336394A JP2000165716A (ja) | 1998-06-04 | 1998-11-26 | ビデオカメラシステム |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1272794A true CN1272794A (zh) | 2000-11-08 |
CN100348268C CN100348268C (zh) | 2007-11-14 |
Family
ID=33033296
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98102335A Pending CN1203805A (zh) | 1998-06-04 | 1998-06-04 | 防治月经病证保健饮料 |
CNB998008834A Expired - Lifetime CN100348268C (zh) | 1998-06-04 | 1999-06-07 | 碳化树脂dna免疫吸附剂的制备方法 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN98102335A Pending CN1203805A (zh) | 1998-06-04 | 1998-06-04 | 防治月经病证保健饮料 |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1001618A1 (zh) |
JP (1) | JP2000165716A (zh) |
CN (2) | CN1203805A (zh) |
AU (1) | AU708728B1 (zh) |
CA (1) | CA2252786C (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100345875C (zh) * | 2005-12-21 | 2007-10-31 | 南开大学 | 含极性基团的吸附树脂的制备方法及该树脂在高纯度血根碱制备中的应用 |
CN106994336A (zh) * | 2016-01-25 | 2017-08-01 | 于杰 | 适用于精准血液净化疗法的医用吸附树脂 |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2357648A (en) * | 1999-12-21 | 2001-06-27 | Heping He | Portable internet-camcorder |
AU2000272667A1 (en) | 2000-09-13 | 2002-04-29 | Jiangsu Kanion Pharmaceutical Co. | Pharmaceutical composition treating gynecological blood stasis diseases, cardio and cerebral vascular diseases, respiratory diseases and the like |
US6798391B2 (en) * | 2001-01-02 | 2004-09-28 | Xybernaut Corporation | Wearable computer system |
US20040201695A1 (en) * | 2001-02-15 | 2004-10-14 | Rei Inasaka | System for delivering news |
CN1208085C (zh) * | 2003-09-03 | 2005-06-29 | 山东新时代药业有限公司 | 一种治疗月经过多的中药组合物及其制剂和制备方法 |
CN100515478C (zh) * | 2004-01-02 | 2009-07-22 | 秦皇岛市山海关制药厂 | 治疗经前期综合征的中药组合物 |
CN1320914C (zh) * | 2005-04-08 | 2007-06-13 | 周鑫 | 调经散 |
CN101495129B (zh) | 2006-10-18 | 2014-01-15 | 江苏康缘药业股份有限公司 | 桂枝茯苓组合物及其应用 |
CN1994453B (zh) * | 2006-12-28 | 2010-10-06 | 王玉秀 | 一种治疗气滞血瘀型痛经的内服中药 |
CN100998720B (zh) * | 2006-12-28 | 2010-09-29 | 王玉秀 | 一种治疗胞宫瘀滞型闭经的内服中药 |
CN101919957B (zh) * | 2009-06-09 | 2013-04-24 | 邓步梓 | 一种医治女性痛经的药茶及其制备方法 |
CN103371425A (zh) * | 2012-04-24 | 2013-10-30 | 陈金奎 | 一种用于逐湿寒、理气血、养肠胃、镇咳平喘祛痰、安胎、增加人体抵抗力的饮品 |
CN103536892B (zh) * | 2013-11-07 | 2015-04-08 | 青岛市市立医院 | 一种治疗阳虚寒凝证型不孕病的中药 |
CN105168729A (zh) * | 2014-11-27 | 2015-12-23 | 青岛申达高新技术开发有限公司 | 一种治疗湿热癖阻型痛经的中药组合物及其制备方法 |
CN104436051A (zh) * | 2014-12-08 | 2015-03-25 | 成都锦汇科技有限公司 | 一种可长期服用的保健型冲剂 |
CN104399000A (zh) * | 2014-12-11 | 2015-03-11 | 青岛百瑞吉生物工程有限公司 | 用于治疗月经不调的中药制剂及其制作方法和应用 |
CN105214028A (zh) * | 2015-09-29 | 2016-01-06 | 罗奕珺 | 一种药物组合物用于制备治疗闭经药物中的用途 |
CN105535620A (zh) * | 2016-01-13 | 2016-05-04 | 岳晓燕 | 一种治疗痛经的中药汤剂 |
CN105664868A (zh) * | 2016-01-22 | 2016-06-15 | 广州康盛生物科技有限公司 | 血液净化用内毒素吸附材料及其制备方法与应用 |
CN105847627B (zh) * | 2016-03-30 | 2018-11-23 | 北京小米移动软件有限公司 | 一种显示图像数据的方法和装置 |
CN105995585A (zh) * | 2016-05-20 | 2016-10-12 | 济南银中容和堂药业有限公司 | 牡丹阿胶保健食品 |
CN106215104A (zh) * | 2016-08-24 | 2016-12-14 | 沈友良 | 一种治疗月经不调、闭经的中药组合物 |
US10499001B2 (en) | 2017-03-16 | 2019-12-03 | Gvbb Holdings S.A.R.L. | System and method for augmented video production workflow |
CN108740200A (zh) * | 2018-06-15 | 2018-11-06 | 黄汉章 | 一种痛经茶及其制备方法 |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0272792B1 (en) * | 1986-11-21 | 1994-09-14 | Imre Corporation | Antigen-specific removal of circulating immune complexes |
US5363264A (en) * | 1990-04-25 | 1994-11-08 | The United States Of America As Represented By The Secretary Of The Navy | Versatile digital recording system for recording high resolution video imagery |
FR2695530A1 (fr) * | 1992-09-10 | 1994-03-11 | Sopro Sa | Dispositif de saisie d'image intégré dans un sytème informatique. |
US5475441A (en) * | 1992-12-10 | 1995-12-12 | Eastman Kodak Company | Electronic camera with memory card interface to a computer |
FR2705152B1 (fr) * | 1993-05-10 | 1995-08-04 | Meriaux Delbarre Romain | Equipement de prise de vues a distance, autonome. |
JP3399698B2 (ja) * | 1994-08-23 | 2003-04-21 | 株式会社日立製作所 | カメラ付き記録装置 |
DE19534450A1 (de) * | 1995-09-16 | 1997-03-20 | Sel Alcatel Ag | Videotelephoneinrichtung |
JPH09114543A (ja) * | 1995-10-02 | 1997-05-02 | Xybernaut Corp | ハンドフリーコンピュータ装置 |
US6870566B1 (en) * | 1995-12-07 | 2005-03-22 | Canon Kabushiki Kaisha | Image sensing system for sensing an image and converting the image into image signals with a controlled operating rate |
JP3732572B2 (ja) * | 1996-05-16 | 2006-01-05 | 株式会社日立製作所 | ビデオカメラ付き記録装置 |
JPH10301196A (ja) * | 1997-04-28 | 1998-11-13 | Fuji Photo Optical Co Ltd | カメラの遠隔操作装置 |
-
1998
- 1998-06-04 CN CN98102335A patent/CN1203805A/zh active Pending
- 1998-11-04 CA CA002252786A patent/CA2252786C/en not_active Expired - Fee Related
- 1998-11-04 AU AU90525/98A patent/AU708728B1/en not_active Ceased
- 1998-11-11 EP EP98309219A patent/EP1001618A1/en not_active Withdrawn
- 1998-11-26 JP JP10336394A patent/JP2000165716A/ja active Pending
-
1999
- 1999-06-07 CN CNB998008834A patent/CN100348268C/zh not_active Expired - Lifetime
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100345875C (zh) * | 2005-12-21 | 2007-10-31 | 南开大学 | 含极性基团的吸附树脂的制备方法及该树脂在高纯度血根碱制备中的应用 |
CN106994336A (zh) * | 2016-01-25 | 2017-08-01 | 于杰 | 适用于精准血液净化疗法的医用吸附树脂 |
Also Published As
Publication number | Publication date |
---|---|
EP1001618A1 (en) | 2000-05-17 |
CN100348268C (zh) | 2007-11-14 |
CN1203805A (zh) | 1999-01-06 |
CA2252786A1 (en) | 2000-05-04 |
JP2000165716A (ja) | 2000-06-16 |
CA2252786C (en) | 2002-05-07 |
AU708728B1 (en) | 1999-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN1272794A (zh) | 碳化树脂dna免疫吸附剂的制备方法 | |
CN101224415B (zh) | 用于体外全血灌流吸附低密度脂蛋白的吸附剂及制备方法 | |
CN105126784B (zh) | 吸附剂及其制备方法、用于血液灌流的吸附装置 | |
CN104174385B (zh) | 一种用于血液灌流的胆红素吸附剂 | |
CN107486176A (zh) | 一种用于血液净化的吸附材料及其制备方法 | |
JPS62242628A (ja) | プロテインa−シリカ免疫吸着剤及びその製造方法 | |
CN104959120B (zh) | 一种用于血液灌流的炎性因子吸附剂及制备方法 | |
CN106268703A (zh) | Dna免疫吸附剂及其制备方法 | |
CN105709705B (zh) | 清除血液胆红素的分子印迹吸附剂及其制备方法 | |
CN108031454A (zh) | 具备物理特异选择性的血液净化吸附剂及其制备方法 | |
CN111659355A (zh) | 烷基化修饰的乙肝病毒免疫吸附剂及其制备方法 | |
CN106238023B (zh) | 一种用于改善血液净化材料表面生物相容性的包膜方法 | |
JPS5944286B2 (ja) | 牛トロンビンの精製法 | |
CN107754764A (zh) | 一种高载量的蛋白a免疫吸附材料及其制备方法 | |
CN1209548A (zh) | 碳化树脂dna免疫吸附剂的制备方法 | |
CN101961512A (zh) | 一种乙型肝炎病毒亲和吸附柱及其制备方法 | |
Xu et al. | Studies of adsorbents for hemoperfusion in artificial liver support. I. Preparation and in vitro studies of cross-linked agarose beads entrapped activated charcoal (CAAC) | |
CN106038591A (zh) | 一种含黄芪多糖铁的猪用注射液 | |
CN103394331B (zh) | 一种丙型肝炎病毒吸附剂及其制备方法与应用 | |
KR100978169B1 (ko) | 면역 억제 물질 흡착재, 체외 순환 컬럼 및 암의 치료방법 | |
JPS62191042A (ja) | 血液凝固第8因子吸着体およびそれを用いた血液凝固第8因子の精製法 | |
CN108578693B (zh) | 用于治疗艾滋病的自体血浆灭活疫苗的光化学制备方法 | |
Ptak et al. | Immunoadsorption therapy and complement activation | |
WO1983004180A1 (en) | Immobilized pepsin for removing blood immune complex and method for removing blood immune complex using immobilized pepsin | |
CN1431025A (zh) | 一种血液内乙型肝炎病毒免疫吸附柱 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Zhuhai Lizhu Medical Bio-material Co., Ltd. Assignor: Nankai University Contract fulfillment period: 2008.7.10 to 2019.6.6 Contract record no.: 2009440000196 Denomination of invention: Method for preparing carbide resin DNA immunity adsorbent Granted publication date: 20071114 License type: Exclusive license Record date: 2009.3.19 |
|
LIC | Patent licence contract for exploitation submitted for record |
Free format text: EXCLUSIVE LICENSE; TIME LIMIT OF IMPLEMENTING CONTACT: 2008.7.10 TO 2019.6.6; CHANGE OF CONTRACT Name of requester: ZHUHAI LIZHU MEDICAL BIOMATERIALS CO., LTD. Effective date: 20090319 |
|
EM01 | Change of recordation of patent licensing contract |
Change date: 20100311 Contract record no.: 2009440000196 Assignee after: Zhuhai Livzon Pharmacy Material Co., Ltd. Assignee before: Zhuhai Lizhu Medical Bio-material Co., Ltd. |
|
ASS | Succession or assignment of patent right |
Owner name: ZHUHAI JAFRON BIOMEDICAL CO., LTD. Free format text: FORMER OWNER: NANKAI UNIVERSITY Effective date: 20110610 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 300071 NO. 94, WEIJIN ROAD, NANKAI DISTRICT, TIANJIN, CHINA TO: 519080 4-5/F, BUILDING 5, BUILDING 4, AREA 3, NO. 99, ZHUHAI DAXUE ROAD, ZHUHAI CITY, GUANGDONG PROVINCE |
|
TR01 | Transfer of patent right |
Effective date of registration: 20110610 Address after: 519080, 4, 3, 99, 4, 5, 5, University Road, Zhuhai, Guangdong, Zhuhai Patentee after: Jafron Biomedical Co., Ltd. Address before: 300071 China Tianjin Nankai District Wei Jin Road No. 94 Patentee before: Nankai University |
|
CP01 | Change in the name or title of a patent holder |
Address after: 519080 4, 5 4 and 5 floors, District 3, 99 Zhuhai University Road, Zhuhai City, Guangdong Province Patentee after: Jianfan Biotechnology Group Co., Ltd. Address before: 519080 4, 5 4 and 5 floors, District 3, 99 Zhuhai University Road, Zhuhai City, Guangdong Province Patentee before: Jafron Biomedical Co., Ltd. |
|
CP01 | Change in the name or title of a patent holder | ||
CX01 | Expiry of patent term |
Granted publication date: 20071114 |
|
CX01 | Expiry of patent term |